ALLR

0.78509.25%
GW

Gerald W. McLaughlin

Independent Chairman of the Board

Mr. Gerald W. McLaughlin, also known as Jerry, MBA, is CEO & Director of Life Biosciences, Inc. Mr. McLaughlin has been an Independent Director of Allarity Therapeutics, Inc. since October 1, 2022 and serves as its Chairman since January 2023. He had been the Chief Executive Officer and President of Neos Therapeutics, Inc. since June 27, 2018 until March 19, 2021 and served as its Director since June 2018 until March 19, 2021. He served as Director at Aytu Biopharma, Inc. (formerly, Aytu BioScience, Inc.) since March 19, 2021 until May 17, 2021. Mr. McLaughlin served as Chief Executive Officer and President of AgeneBio, Inc. since June 2014 until June 27, 2018. Mr. McLaughlin served as the Chief Commercial Officer and Senior Vice President at NuPathe, Inc., since October 2012 until 2014. He served as Vice President of Commercial Operations of NuPathe Inc. since September 2007. He has specialty pharmaceutical industry experience in the U.S. and globally in new products planning, brand marketing and sales. Mr. McLaughlin was at Endo Pharmaceuticals from 2001 to 2007 and served in a variety of commercial leadership roles at Merck from 1990 to 2001. Mr. McLaughlin has launched twelve brands in a variety of therapeutic categories and has a strong background in strategic planning and commercial assessment. He worked in increasingly responsible positions at Endo Pharmaceuticals. In his last position as Senior Director of Strategic Marketing, Mr. McLaughlin led its portfolio planning efforts as well as commercial assessments and licensing and acquisition opportunities in Neurology, Supportive Care Oncology and Pain Management. He worked at Merck & Co. Inc., where he started as a sales representative and served as an Associate Director of Marketing in the Worldwide Human Health Division of Merck & Co. Inc. and was responsible for developing global business and product lifecycle plans for Merck products. He served as Regional Sales Director at Endo. He joined Endo in 2001 as Marketing Director and subsequently served as Group Marketing Director, Pain Products from 2002 to 2005. He served as Marketing Manager for Vioxx and Market Research Analyst for Proscar and Propecia. He served as an Independent Director at Nemus Bioscience Inc. since October 2014 until January 18, 2018. Mr. McLaughlin has a B.A in Economics from Dickinson College and an MBA from Villanova University. Mr. McLaughlin is currently the chief executive officer and board member of Life Biosciences LLC, a biotechnology company, since 2021.

Positions